Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04461171 · ClinicalTrials.gov registry record · NA
Enhanced Recovery After Surgery in Extremity Sarcoma
A NA study of Sarcoma, sponsored by Joshua Lawrenz.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04461171: Recruiting NA study of Sarcoma, sponsored by Joshua Lawrenz.
NCT04461171 is a NA study of Sarcoma that is actively recruiting participants, run by Joshua Lawrenz. The registered enrollment target is 120 participants, below the 920-participant average among 122 other Sarcoma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04461171, a NA study of Sarcoma, is actively recruiting participants, sponsored by Joshua Lawrenz.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
Primary Outcome
Measured by Quality of Recovery questionnaire (QoR-15) scale = 0-10 (0=none of the time and 10 = all of the time)
Conditions Studied
Interventions
- PROCEDURE Enhanced Recovery After Surgery
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT04461171 shows while recruiting
NCT04461171 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 920-participant average among 122 other Sarcoma trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Enhanced Recovery After Surgery is the first listed.
NCT04461171 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04461171 about?
NCT04461171 is a clinical study titled "Enhanced Recovery After Surgery in Extremity Sarcoma". The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
What is the current status of trial NCT04461171?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2020-12-14. Estimated completion is 2026-06.
What conditions does trial NCT04461171 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT04461171?
The interventions under investigation include: Enhanced Recovery After Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT04461171?
This trial is sponsored by Joshua Lawrenz, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04461171 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04461171's enrollment target sits among peer trials
120 37th of 122 higher than 85 of 122 other Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients
RECRUITING · NA
-
A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma
RECRUITING · NA
-
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
RECRUITING · NA
-
GRID Therapy for Extremity Soft Tissue Sarcoma
RECRUITING · NA
-
Video Education With Result Dependent dIsclosure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy